European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart failure symptoms, physical limitations, and exercise function in patients with obesity-related HFpEF.
Heart failure arises when the heart cannot pump blood efficiently, leading to symptoms such as shortness of breath and ...
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...
In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...
CINCINNATI ( WXIX /Gray News) - A 7-year-old is in a hospital in Ohio fighting for her life after experiencing her second heart failure. Nyla Pritchett has been at Cincinnati Children’s Hospital since ...
A woman fighting for her life and battling heart failure was able to take part in an an experience her whole family will ...
Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. In ...
Pregnancy-Related Heart Failure Is Under-Detected; AI-Enabled Stethoscope Helped Doctors Diagnose Twice as Many Cases Sep. 3, 2024 — Heart failure during pregnancy is a dangerous and often ...
The enzyme converts heart fibroblasts to myofibroblasts, putting the heart's integrity at risk. Deleting this enzyme reduced ...
Root canal treatment is a common dental procedure aimed at saving damaged or infected teeth. Despite concerns about its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback